Beam Therapeutics (BEAM) Other Non Operating Income (2019 - 2026)

Beam Therapeutics (BEAM) has reported Other Non Operating Income for 8 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income fell 21.88% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $10.4 million (up 24.32% YoY), while the FY2025 annual figure was $10.2 million, up 347.54% from the prior year.
• Other Non Operating Income eased to $2.5 million in Q1 2026 per BEAM's latest filing, from $9.5 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $13.6 million in Q1 2022 and bottomed at -$4.9 million in Q3 2022.
• Historically, Other Non Operating Income has averaged $2.8 million across 5 years, with a median of $2.5 million in 2026.
• On a YoY basis, Other Non Operating Income climbed as much as 7535.94% in 2025 and fell as far as 1278.5% in 2025.
• Beam Therapeutics' Other Non Operating Income stood at $3.0 million in 2022, then sank by 163.33% to -$1.9 million in 2023, then soared by 93.26% to -$128000.0 in 2024, then jumped by 7535.94% to $9.5 million in 2025, then tumbled by 73.73% to $2.5 million in 2026.
• Business Quant data shows BEAM's Other Non Operating Income at $2.5 million in Q1 2026, $9.5 million in Q4 2025, and -$2.8 million in Q3 2025.